Granulomatous amoebic encephalitis medical therapy

	Granulomatous amoebic encephalitis Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Granulomatous amoebic encephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural history, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Case Studies
Case #1
Granulomatous amoebic encephalitis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Granulomatous amoebic encephalitis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Granulomatous amoebic encephalitis medical therapy
CDC on Granulomatous amoebic encephalitis medical therapy
Granulomatous amoebic encephalitis medical therapy in the news
Blogs on Granulomatous amoebic encephalitis medical therapy
Directions to Hospitals Treating Granulomatous amoebic encephalitis
Risk calculators and risk factors for Granulomatous amoebic encephalitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Granulomatous amoebic encephalitis is a central nervous system disease caused by certain species of amoeba, especially Balamuthia mandrillaris.